OneAI™ for Biosimilar Comparability
An Additional Analytical Layer for Demonstrating Similarity
OneAI™ provides repeatable, multidimensional biospectral characterization designed to support comparison between biosimilar and reference biologic products.
Compare More Than a Single Measurement
Biosimilar development depends on demonstrating that a proposed product is highly similar to its reference product.
OneAI™ can compare biospectral quality signatures across products, samples, batches and dose levels—providing objective measurements of similarity, consistency and meaningful change.
It is designed to complement established analytical methods, not replace them, by adding a repeatable multidimensional characterization layer to analytical comparability.
From Comparability to Commercial Application
Purity Biologics is developing comparative-analytical frameworks designed to incorporate OneAI™ into drug-specific biosimilar comparability and dose-level quality programs.
These frameworks provide a pathway from analytical characterization and OneAI training through comparability studies and commercial validation—ultimately supporting deployment of OneAI within biologic development and manufacturing.